Rxivist logo

Ferritin nanoparticle based SARS-CoV-2 RBD vaccine induces persistent antibody response and long-term memory in mice

By Wenjun Wang, Baoying Huang, Yanping Zhu, Wenjie Tan, Mingzhao Zhu

Posted 23 Dec 2020
bioRxiv DOI: 10.1101/2020.12.22.423894

Since the outbreak of COVID-19, over 200 vaccine candidates have been documented and some of them have advanced to clinical trials with encouraging results. However, the antibody persistence over 3 months post immunization and the long-term memory have been rarely reported. Here, we report that a ferritin nanoparticle based SARS-CoV-2 RBD vaccine induced in mice an efficient antibody response which lasts for at least 7 months post immunization. Significantly higher number of memory B cells were maintained and a significantly higher level of recall response was induced upon antigen challenge. Thus, we believe our current study provide the first information about the long-term antibody persistence and memory response of a COVID-19 vaccine. This information would be also timely useful for the development and evaluation of other vaccines.

Download data

  • Downloaded 545 times
  • Download rankings, all-time:
    • Site-wide: 66,291
    • In immunology: 2,020
  • Year to date:
    • Site-wide: 24,160
  • Since beginning of last month:
    • Site-wide: 67,539

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide